Brief: ORIC Pharmaceuticals Q1 Net Income USD -25.011 Million
06/05/2024 21:05
May 06 (Reuters) - ORIC Pharmaceuticals Q1 operating expenses USD 28.99 million. * Q1 basic EPS USD -0.37 vs. IBES estimate USD -0.44 * Q1 income from operations USD -28.99 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows